ChernyNI, PortenoyRK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care1994; 10 (2):31–38.
2.
BrockDW. Children's competence for health care decision making. In: KopelmanLM, MoskopJC (eds). Children and Health Care: Moral and Social Issues. Boston: Kluwer Academic Publishers, 1989; 181–212.
3.
ColesR.The Spiritual Life of Children. Boston: Houghton Mifflin Company, 1990.
4.
BerdeC, AblinA, GlazerJ, . Report of the subcommittee on disease-related pain in childhood cancer. Pediatrics1990; 86: 818–825.
FragerG.Relieving suffering in children with malignant disease. In: ArbitE (ed). Management of Cancer-Related Pain. New York: Futura Publishing Co., 1993; 193–205.
7.
GoldmanA (ed). Care of the Dying Child. Oxford: Oxford University Press, 1994.
8.
MiserAW. Management of pain associated with childhood cancer. In: SchechterNL, BerdeCB, YasterM, (eds). Pain in Infants, Children, and Adolescents. Baltimore: Williams and Wilkins, 1993; 411–424.
9.
SchechterNL, BerdeCB, YasterM (eds). Pain in Infants, Children and Adolescents, Baltimore, MD: Williams and Wilkins, 1993.
ChernyNI, CoyleN, FoleyKM. Guidelines in the care of the dying cancer patient. Hematology/Oncology Clinics of North America1996; 10: 261–286.
12.
GreeneWR, DavisWH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. Southern Medical Journal1991; 84: 332–337.
13.
GrimshawD, HolroydE, AnthonyD, HallDMB. Subcutaneous midazolam, diamorphine and hyoscine infusion in palliative care of a child with neurodegenerative disease. Child Care Health Dev1995; 21 (6):377–381.
14.
McIverB, WalshD, NelsonK.The use of chlorpromazine for symptom control in dying cancer patients. J Pain Sympt Manag1994; 9 (5):341–345.
15.
CollinsJJ, GrierHE, KinneyHC. Control of severe pain in children with terminal malignancy. J Pediatr1995; 126: 653–657
16.
Agency for Health Care Policy and Research Acute Pain Management Panel. Acute Pain Management: Operative or Medical Procedures and Trauma. Washington, DC: US Department of Health and Human Services, 1992.
17.
SzetoHH, InturrisiCE, HoudeR, . Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure or cancer. Ann Intern Med1977; 86: 738.
18.
KaikoRF, FoleyKM, GrabinskiPV, . Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol1983; 13: 180.
MercadanteS, De ConnoF, RipamontiC.Propofol in terminal care. J Pain Sympt Manag1995; 10: 639–642.
21.
MoyleJ.The use of propofol in palliative medicine. J Pain Sympt Manag1995; 10: 643–646.
22.
ReadyLB, EdwardsWT (eds). Management of Acute Pain: A Practical Guide. International Association for the Study of Pain, Task Force on Acute Pain.Seattle: IASP Publications, 1992; 20.